Login | Register

ADUSAVE (loxapine) Inhalation Powder Approved For Schizophrenia Or Bipolar Agitation

ADASUVE (loxapine) Inhalation Powder has just been approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of agitation resulting from schizophrenia or bipolar I disorder. They anticipate that the treatment will be available around the third quarter of 2013...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *